The endoscope reprocessing market has seen considerable growth due to a variety of factors.
• The market for endoscope reprocessing has seen a fast-paced growth lately. The market value is predicted to rise from $2.74 billion in 2024 to $3.03 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.9%.
The surge in its growth during the historic period is due to the strict regulatory compliance, augmented use of endoscopy, heightened awareness about infection control measures and patient safety problems, alongside an increase in the senior population.
The endoscope reprocessing market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for endoscope reprocessing is projected to experience a substantial acceleration in its growth trajectory in the forthcoming years. It is slated to reach a value of $4.83 billion by 2029, registering a compound annual growth rate (CAGR) of 12.3%.
Factors contributing to the market growth during the forecast period include heightened incorporation of artificial intelligence (AI), prevalence of global pandemics, an increased focus on environmental sustainability, the rise of telemedicine and remote procedures, and a shift towards value-based healthcare. Key predicted trends for the forecast period are automation and robotics, data-centric compliance, the use of disposable endoscopes, modular design in endoscopes, and advances in infection control.
The surge in cancer cases is anticipated to boost the expansion of the endoscope reprocessing market. Cancer develops when certain cells in the body gain an uncontrollable growth rate, spreading to various other parts of the body. It's a condition that can take root in any of the millions of cells present in the human body. Endoscope reprocessing works towards the cleaning, disinfection, and sterilization of these cells. Factors such as an increasing population and enhanced exposure to infection contribute to chronic diseases. To illustrate, the National Institutes of Health, a government agency in the U.S., stated in May 2024 that around 18.1 million individuals in the US were surviving cancer as of January 2022. They also projected an increase in this figure to 22.5 million by 2032. Consequently, the burgeoning occurrence of cancer is spurring the endoscope reprocessing market's growth.
The endoscope reprocessing market covered in this report is segmented –
1) By Type: Flexible, Rigid
2) By Product: High-Level Disinfectants and Test Strips, Other Products
3) By End-User: Hospitals, Ambulatory Surgical Centers and Clinics, Other End-Users
Subsegments:
1) By Flexible Endoscopes: Gastrointestinal Endoscopes, Respiratory Endoscopes, Urological Endoscopes, Other Flexible Endoscopes
2) By Rigid Endoscopes: Arthroscopes, Cystoscopes, Laparoscopes, Other Rigid Endoscopes
Top-tier businesses in the endoscope reprocessing market are putting their focus on creating novel solutions, such as the ED-Flow Automated Endoscope Reprocessor, to augment the safety and efficiency of the endoscope sterilization and cleaning procedures. The aforementioned system is a cutting-edge technology designed specifically for disinfecting and cleaning endoscopes in healthcare contexts. For example, Getinge, which is headquartered in Sweden and operates in the healthcare sector, introduced an improved version of its ED-Flow automated endoscope reprocessor in June 2022, characterized by advanced digital connectivity and superior data management functions. This updated model efficiently conducts leak testing, cleanses, and performs high-level disinfection of flexible endoscopes, while integrating process indicator lights for better workflow monitoring. Furthermore, it links to Getinge's T-DOC traceability software and the Getinge Online portal to facilitate real-time tracking and access to historic data.
Major companies operating in the endoscope reprocessing market include:
• Custom Ultrasonics Inc.
• Advanced Sterilization Products Inc.
• Olympus Corporation
• Wassenburg Medical BV
• Steris Corporation
• Getinge AB
• ARC Healthcare Solutions
• BES Healthcare Ltd.
• Borer Chemie AG
• Metrex Research LLC
• Matachana Group SA
• HOYA Corporation
• Laboratories Anios
• CONMED Corporation
• Endo-Technik W. Griesat GmbH
• Steelco S.p.A
• Ecolab Inc.
• Belimed AG
• Cantel Medical Corp.
• Richard Wolf GmbH
• MEDALKAN
• Micro-Scientific LLC
• Tuttnauer USA Co. Ltd.
• Shinva Medical Instrument Co. Ltd.
• Medical Devices Group Srl
• SciCan Inc.
North America was the largest region in the endoscope reprocessing market in 2024. The regions covered in the endoscope reprocessing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.